デフォルト表紙
市場調査レポート
商品コード
968767

幹細胞市場 - タイプ・アプリケーション・技術・地域別:市場規模・シェア・展望・機会分析 (2020-2027年)

Stem Cells Market, By Type, By Application, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 187 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円
幹細胞市場 - タイプ・アプリケーション・技術・地域別:市場規模・シェア・展望・機会分析 (2020-2027年)
出版日: 2020年10月07日
発行: Coherent Market Insights
ページ情報: 英文 187 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

幹細胞は2つの主要なクラス - 多能性幹細胞および多能性幹細胞に分けられます。多能性幹細胞は、胚または胎児組織に由来する複製細胞です。多能性幹細胞は、中胚葉、外胚葉、内胚葉などの3つの主要な胚葉における細胞と組織の発達を促進します。予測期間中に幹細胞市場の成長を妨げる主な要因は、高コストおよび熟練専門家の不足です。

当レポートでは、世界の幹細胞市場について調査し、市場の概要、市場に影響を及ぼす要因の分析、各セグメント・地域別の市場分析、主要企業のプロファイルなどを提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場内訳:タイプ別
    • 市場内訳:アプリケーション別
    • 市場内訳:技術別
  • Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • PEST分析
  • COVID-19影響分析

第4章 世界の幹細胞市場:タイプ別

  • イントロダクション
  • 成体幹細胞
  • ヒト胚性幹細胞
  • 人工多能性幹細胞
  • 天然ロゼット細胞
  • 極小胚様幹細胞 (VSEL)
    • イントロダクション
    • 市場規模と予測、および前年比成長率
    • セグメント動向

第5章 世界の幹細胞市場:アプリケーション別

  • イントロダクション
  • 再生医療
  • 創薬&開発
    • イントロダクション
    • 市場規模と予測、および前年比成長率
    • セグメント動向

第6章 世界の幹細胞市場:技術別

  • イントロダクション
  • 細胞獲得
  • 細胞生産
  • 凍結保存
  • 増殖&二次培養
    • イントロダクション
    • 市場規模と予測、および前年比成長率
    • セグメント動向

第7章 世界の幹細胞市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • フランス
    • スペイン
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • ASEAN
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東
    • GCC諸国
    • イスラエル
    • その他中東
  • アフリカ
    • 北アフリカ
    • 中央アフリカ
    • 南アフリカ

第8章 競合情勢

  • 企業プロファイル
    • Advanced Cell Technology, Inc.
    • Angel Biotechnology Holdings PLC
    • Bioheart Inc.
    • Lineage Cell Therapeutics
    • BrainStorm Cell Therapeutics, Inc.
    • California Stem Cell Inc.
    • Celgene Corporation
    • Takara Bio Europe AB
    • Cellular Engineering Technologies
    • Cytori Therapeutics Inc.
    • Osiris Therapeutics
    • STEMCELL Technologies Inc

第9章 セクション

目次

Title:
Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Restraints of the Global Stem Cells Market

Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.

Key features of the study:

  • This report provides in-depth analysis of the global stem cells market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global stem cells market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Stem Cells Market, By Type:
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market, By Application:
    • Regenerative Medicine
    • Drug Discovery and Development
  • Global Stem Cells Market, By Technology:
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market, By Geography:
    • North America
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Type
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • By Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • By Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Advanced Cell Technology, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Angel Biotechnology Holdings PLC
    • Bioheart Inc.
    • Lineage Cell Therapeutics
    • BrainStorm Cell Therapeutics, Inc.
    • California Stem Cell Inc.
    • Celgene Corporation
    • Takara Bio Europe AB
    • Cellular Engineering Technologies
    • Cytori Therapeutics Inc.
    • Osiris Therapeutics
    • STEMCELL Technologies Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Application
  • Market Snippet, By Technology
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Stem Cells Market, By Type, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Adult Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Human Embryonic Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Induced Pluripotent Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Natural Rosette Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Very Small Embryonic Like Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Stem Cells Market, By Application, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Stem Cells Market, By Technology, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Cell Acquisition
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cell Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cryopreservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Expansion and Sub-Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Stem Cells Market, By Regions, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Advanced Cell Technology, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Angel Biotechnology Holdings PLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bioheart Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lineage Cell Therapeutics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainStorm Cell Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • California Stem Cell Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celgene Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Europe AB
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellular Engineering Technologies
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytori Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Osiris Therapeutics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • STEMCELL Technologies Inc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact